Tinkeso Therapeutics
Health Care · Regenerative Medicine
Overview
Is to address the patient unmet needs with our novel off-the-shelf, allogeneic Natural Killer T (NKT) cell therapies for the treatment of cancers and other immune-mediated disorders.. Tinkeso Therapeutics, Inc, formally Akeso Therapeutics, is an early-stage biotech company based in Valhalla, NY.
Funding and backers
Team
1-10
employees, estimated range
Backers
1
SOSV
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2017
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Exthymic is an early-stage deep-tech startup that develops point-of-care manufacturing systems for patient-specific cell therapies. Its…
Wugen is now Allotera A new era of Allogeneic T-Cell Therapies Continue to Allotera If you have any questions please contacts us at…
Building programmable in vivo immune-cell therapies across oncology and autoimmune disease.
We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Developing next-generation cell therapies utilizing engineered biomaterial technologies.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
SOSVVia a fund
780 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely